May 8, 2018 / 10:20 AM / 5 months ago

BRIEF-Cellular Biomedicine Group Qtrly Loss Per Share $0.51

May 8 (Reuters) - Cellular Biomedicine Group Inc:

* CELLULAR BIOMEDICINE GROUP REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS

* CELLULAR BIOMEDICINE GROUP INC - ENDED QUARTER WITH $45.6 MILLION IN CASH

* CELLULAR BIOMEDICINE GROUP INC - QTRLY LOSS PER SHARE $0.51 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below